Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine M Guinn

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Mbio|December 21, 2017
Tuberculosis: Just the FAQsKristine M Guinn, Eric J Rubin
China CDC Weekly|October 1, 2021
Implementing New Approaches to Tuberculosis ControlKristine M Guinn, Eric J Rubin
The New England Journal of Medicine|September 15, 2025
Reducing Tobacco Use Worldwide - A New Perspective SeriesNancy A Rigotti, Kamran Siddiqi, Debra Malina, et al.
Nature Communications|April 25, 2020
Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosisRobert S Jansen, Lungelo Mandyoli, Ryan Hughes, et al.
Mbio|February 20, 2014
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteriaIrina A Rodionova, Brian M Schuster, Kristine M Guinn, et al.
Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Development of an Engineered <i>Mycobacterium tuberculosis</i> Strain for a Safe and Effective Tuberculosis Human Challenge ModelXin Wang, Hongwei Su, Joshua B Wallach, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2022
Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacyEun-Ik Koh, Peter O Oluoch, Nadine Ruecker, et al.
Nature Microbiology|January 10, 2025
Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal modelsXin Wang, Hongwei Su, Joshua B Wallach, et al.
Nature|June 21, 2019
Large-scale chemical-genetics yields new M. tuberculosis inhibitor classesEachan O Johnson, Emily LaVerriere, Emma Office, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Mbio|December 21, 2017
Tuberculosis: Just the FAQsKristine M Guinn, Eric J Rubin
China CDC Weekly|October 1, 2021
Implementing New Approaches to Tuberculosis ControlKristine M Guinn, Eric J Rubin
The New England Journal of Medicine|September 15, 2025
Reducing Tobacco Use Worldwide - A New Perspective SeriesNancy A Rigotti, Kamran Siddiqi, Debra Malina, et al.
Nature Communications|April 25, 2020
Aspartate aminotransferase Rv3722c governs aspartate-dependent nitrogen metabolism in Mycobacterium tuberculosisRobert S Jansen, Lungelo Mandyoli, Ryan Hughes, et al.
Mbio|February 20, 2014
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteriaIrina A Rodionova, Brian M Schuster, Kristine M Guinn, et al.
Plos One|October 3, 2013
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosisThomas R Ioerger, Theresa O'Malley, Reiling Liao, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
Development of an Engineered <i>Mycobacterium tuberculosis</i> Strain for a Safe and Effective Tuberculosis Human Challenge ModelXin Wang, Hongwei Su, Joshua B Wallach, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2022
Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacyEun-Ik Koh, Peter O Oluoch, Nadine Ruecker, et al.
Nature Microbiology|January 10, 2025
Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal modelsXin Wang, Hongwei Su, Joshua B Wallach, et al.
Nature|June 21, 2019
Large-scale chemical-genetics yields new M. tuberculosis inhibitor classesEachan O Johnson, Emily LaVerriere, Emma Office, et al.
Pageof 1